SCHEMBL1269249

SCHEMBL1269249

CCOC(=O)/C=C/CCc1ccc(OC)cc1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 3/20 0.57
GLA P06280 1/20 0.54
KMT2A Q03164 1/20 0.54
CNR1 P21554 3/20 0.50
CNR2 P34972 1/20 0.50
MAPT P10636 2/20 0.48
TBXAS1 P24557 1/20 0.48
F2RL1 P55085 1/20 0.46
ALOX5 P09917 1/20 0.46
ALDH1A1 P00352 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269252 1.00 GPR52 (0.57) GPR52GLAKMT2ACNR1CNR2
SCHEMBL13903166 0.92 CNR1 (0.54) GPR52GLAKMT2ACNR1CNR2
SCHEMBL13971097 0.86 GPR52 (0.61) GPR52GLAKMT2ACNR1CNR2
SCHEMBL16831438 0.86 GPR52 (0.54) GPR52MAPTALDH1A1
SCHEMBL16831439 0.86 GPR52 (0.54) GPR52MAPTALDH1A1
SCHEMBL12035649 0.85 KMT2A (0.49) GLAKMT2AMAPTTBXAS1ALDH1A1
SCHEMBL27712732 0.85 GLA (0.56) GPR52GLAKMT2AMAPTF2RL1
SCHEMBL7340918 0.84 MAPT (0.49) GPR52KMT2AMAPTALDH1A1
SCHEMBL19321725 0.84 GPR52 (0.55) GPR52KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL13903300 0.83 GPR52 (0.58) GPR52MAPTALOX5ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039893-A1 GSK-3BETA INHIBITOR TAKEDA PHARMACEUTICAL COMPANY LIMITED 2011-02-17 US disclosed
US-20090062358-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS CANO IVAN COLLADO 2009-03-05 US disclosed
US-20090062358-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS CANO IVAN COLLADO 2009-03-05 US disclosed
EP-1335908-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS LILLY CO ELI (US) 2008-02-13 EP disclosed
US-7304062-B2 Peroxisome proliferator activated receptor alpha agonists ELI LILLY AND COMPANY (US) 2007-12-04 US disclosed
US-7304062-B2 Peroxisome proliferator activated receptor alpha agonists ELI LILLY AND COMPANY (US) 2007-12-04 US disclosed
US-6720450-B2 USING SUCH AS 7-CYCLOHEXYL-(4,5-METHANO)HEPTANOIC ACID; CONTROLLING BLOOD INGESTING INSECTS NORTH CAROLINA STATE UNIVERSITY 2004-04-13 US disclosed
US-20040034097-A1 Pesticidal activity of functionalized alkenes LINDERMAN RUSSELL J (US) 2004-02-19 US disclosed
US-6660770-B2 Inhibit digestion by terminating or blocking synthesis of digestive enzymes by activating trypsin modulating oostatic factor receptor NORTH CAROLINA STATE UNIVERSITY 2003-12-09 US disclosed
US-20030149103-A1 Pesticidal activity of functionalized cyclopropanes NORTH CAROLINA STATE UNIVERSITY 2003-08-07 US disclosed
WO-2003051118-A1 PESTICIDAL ACTIVITY OF FUNCTIONALIZED CYCLOPROPANES NORTH CAROLINA STATE UNIVERSITY (US) 2003-06-26 WO disclosed
EP-1241941-B1 PESTICIDAL ACTIVITY OF FUNCTIONALIZED ALKENES UNIV NORTH CAROLINA STATE (US) 2003-06-18 EP disclosed
US-6521664-B1 Pesticidal activity of functionalized alkenes NORTH CAROLINA STATE UNIVERSITY 2003-02-18 US disclosed
US-20020193436-A1 Pesticidal activity of functionalized alkenes NORTH CAROLINA STATE UNIVERSITY 2002-12-19 US disclosed
WO-2002098220-A2 PESTICIDAL ACTIVITY OF FUNCTIONALIZED ALKENES NORTH CAROLINA STATE UNIVERSITY (US) 2002-12-12 WO disclosed
EP-1241941-A2 PESTICIDAL ACTIVITY OF FUNCTIONALIZED ALKENES NORTH CAROLINA STATE UNIVERSITY (US) 2002-09-25 EP disclosed
WO-2001041543-A2 PESTICIDAL ACTIVITY OF FUNCTIONALIZED ALKENES NORTH CAROLINA STATE UNIVERSITY (US) 2001-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193436-A1 Pesticidal activity of functionalized alkenes VIP, ANPEP, APEH GPR52 780/4885GLA 2839/4885KMT2A 3115/4885
US-20040034097-A1 Pesticidal activity of functionalized alkenes VIP, ANPEP, APEH GPR52 780/4885GLA 2839/4885KMT2A 3115/4885
US-20110039893-A1 GSK-3BETA INHIBITOR GSK3B, GSK3A, GSKIP GPR52 4536/4885GLA 1520/4885KMT2A 575/4885
US-20030149103-A1 Pesticidal activity of functionalized cyclopropanes DDT, PPIF, CYP4F3 GPR52 2429/4885GLA 3025/4885KMT2A 3464/4885
US-20090062358-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS PPARG, PPARA, PPARD GPR52 53/4885GLA 2097/4885KMT2A 3695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.